<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 105 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page104.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=105">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 105 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 105</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=105"><img src="../thumb/105.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>74 / 2020-04                                                    Musculo-Skeletal Agents - 4.1.2 / 4.1.3
   GI dis.hist., GI bleed./perforat.risk high. with incr.dos.in pts.with ulc.  & ACE inhibit., cholestyram.may.reduc. therapeut. eff., ciclospor. incr.  (S3) TABS, 50/3.1/0301, 0302, 0303
   hist./elderly, concom. oral anticoags., Li plasma conc.monit.when Li   nephrotox.risk, incr. bleed.risk with alcoh., ren.impairm.with diuret.if   723128-001: 60 mg, 28, R226,62.
   ther. init./ withdr., decr.effic.of IUD’s, concom.digoxin, incr. ren.fail.risk,   dehydrat., effic.of IUD’s decr.  723129-001: 90 mg, 7, R57,22
   bld.monit.aft.ther.init.with concom. zidovudine, comprom.card.funct.,   723130-001: 120 mg, 7, R68,56
   condit. predispos. to/ worsen.by fluid retent., dehydrat./ diurets./ un-  MOBIC, Ing.Pharm [P/S]  723130-002: 120 mg, 28, R274,25
   dergone surg.lead.to hypovolaem./ ren./ hepat.dysfunct., CHF, frail/  Meloxicam.  Dosage:.Short.durat.& low.effect.dos. Recomm. dos. are max.dos.
   debilit. pts., induct. of Na/K/ water retent.& poss.interfer.with natriu-  Indications: Symptomat.treatm.of rheumat. arthrit., painf.osteoar-  Re-eval.symptomat.relief/ther. respon.periodic.
   ret.eff.of diurets.may occur, poss.mask sympt. of underly.infect.dis.  thrit.& ankylos.spondylit., ac.sciatica  Osteoarthrit: Recomm.dos: 60 mg once dly.
   Drug interactions: Other NSAID’s/aspir.may incr. GI ulcerat./bleed.  (S3) TABS, [P/S] 29/3.1/0421, 0422  Rheumat.arthrit: Recomm.dos: 90 mg once dly.
   risk, anticoags.incr.bleed. complicat.risks, Li plasma conc.incr., meth-  818615-001: 7,5 mg, 30, R47,54  Ankylos.spondylit: Recomm.dos: 90 mg once dly.
   otrex. toxic., cholestyram.may reduc.therap.eff., nephrotox. meds.  842052-003: 15 mg, 10, R44,40  Ac.pain: Recomm.dos: 90 or 120 mg once dly. limit. to max.8 days.
   incr.nephrotoxic.risk, ren. impairm. with diuret.esp.if dehydrat., incr.  842052-004: 15 mg, 30, R133,32  Ac.gouty arthrit: Recomm.dos: 120 mg once dly. limit.to 8 days
   bleed. risk with alcoh./corticoster./clopidogrel/SSRI/ ticlopidine/bi-  Dosage: Admin.with food.  Prim.dysmenorrh: Recomm.dos: 120 mg once dly.
   sphosphonat./pentoxiphyll., incr. digox. conc., decr.eff.of antihyper-  Rheumat.arthrit: 15 mg/day, reduc.to 7,5 mg/day accord.to respons.  Post-op dent.pain: Recomm.dos: 90 mg once dly.
   tens.agents, hypoglycaem. eff.of antidiab.agents incr., leucopen. &/   Ankylos.spondylit: 15 mg/day, reduc.to 7,5 mg/ day accord.  Contraindications: Act.pept.ulcerat./GI bleed., sev. hepat.dys-
   thrombocytopaen.eff.of bone marr. depress. incr., incr.risk of red cell   to respons.  funct., est.creatinine clear.&lt;30 ml/ min., S&S’s of aspirin/other
   line toxic.effs. with zidovudine.  Osteoarthrit: 7,5 mg/day which may be incr.to 15 mg/day.  NSAID’s cross-sens., uncontrol.hypertens., pregn.& lactat., childr./
                                Ac.sciatica: 7,5 mg/day incr.if necess.to 15 mg/ day if no improvem.  adolesc.und.16 ys., inflamm.bowel dis., sev.CHF (NYHA II- IV), est.
   MELOXICAM UNICORN, Unicorn [P/S]  Max.dos: 15 mg/day.      ischaem.heart dis.and/or cerebrovasc.& periph.arter.dis., peri-op.
   Meloxicam.                   (S3) INJ, [P/S] 29/3.1/0420. 15 mg/1,5 mL
   Indications: Rheumat.arthrit., painf. osteoarthrit., ankylos.spon-  856878-006: 5, R57,69  pain in coron.artery bypass graft surg.setting., not recom. in women
                                                              attempt.to conceive.
   dylit., ac.sciatica          Dosage: Aspirate slowly from amp.to avoid foam. Not to be mix.with
   (S3) TABS, 38/3.1/0495, 0496  other drugs in same syringe. Admin. deep IM for max.of 3 days there-  Side effects: Fluid retent., oed., hypertens.which may be more freq.&
                                                              more sev.partic.at high dos., poss.fatal ser.skin reacts., ser.hypersens.
   716168-001: 7,5 mg, 30, R37,20  aft.cont. with oral prep., use low.effect.dly.dos.for short. durat.poss.
   716169-001: 15 mg, 30, R86,40  Rheumat.arthrit., ankylos.spondylit. & osteoarthrit: Recomm.  reacts. incl. anaphylax.& angioed., alveolar osteit., gastroentirit.,
                                                              URTI, UTI, anaem., leucopen., thrombocytopen., incr./decr.appetite,
   Dosage: Admin.with food. Low.effect.dos.for short.poss.treatm.du-  dos: Indiv: 7,5 mg-15 mg once dly.depend.on pain intens.& sever.
   rat. Adults: Max.dly.dos: 15 mg.  of inflamm.              psych. disords., CNS effs., paraesthes., blurr.vis., conjunctivit., tinnit.,
   Ac.sciatica: 7,5 mg once dly.incr.to 15 mg/day if necess.  Ac.sciatica: 7,5 mg/day incr.if necess.to 15 mg/ day if no improvem.   vertigo, palpitat., atrial fibrillat., CHF, non-specif.ECG changes, MI,
   Ankylos.spondylit: 15 mg/ day.  Contraindications: Signs.of asthma, nas-polyps, angioed., urticar.  angina, aggrav. hypertens., dysrhythm., tachycard., periph. oed., CV
   Osteoarthrit: 7,5 mg once dly.incr.to 15 mg if necess.  foll.aspirin/other NSAID’s, aspirin/ other NSAID’s cross-sensitiv.,   thrombot.events, flush., CVA incid., TIA’s, hypertens. crisis, vasculit.,
   Rheumat.arthrit: 15 mg once dly. Reduc.dos. accord.to respons.  act./hist.of GI ulcerat.or perforat./haemorrh., act.inflamm. bowel   cough, dyspn., epistax., thorac./ mediastin.disords., bronchosp., GI
   Contraindications: Asthma attacks/urticar./ nas. polyps/ ac.rhinit.  dis., sev.hepat.insuffic., non-dialys.sev. ren. insuffic., overt GI bleed.,   disturbs. incl. gastrit./pept.ulc./haemorrh.& fatalit., hepatit., jaund.,
   precip.by aspir./other NSAID, ac.pept.ulc.dis., sev.hepat./non-dialys.  rec.cerebrovasc.bleed., est. system.bleed.disords., uncontrol.HF,   hepat.fail., skin & subcutan. disords.incl.Stev.John.& tox.epiderm.
   ren impairm., HF, GI bleed./perforat.hist.relat.to prev. NSAID, ac./hist.  GI bleed./ perforat./ ulcerat.hist.relat.to prev.NSAID’s, inj: childr./   necrolys, musc.cramps/spasms, musculo-skelet. pain/stiffn., pro-
   of recurr.ulc./haemorrh./perforat., safety & effic.in pregn.& lactat./  adolesc.&lt;18 yrs., peri-op pain in coron. arter. bypass graft surg., con-  teinur., ren.fail./insuffic., fatig./ asthen., flu-like dis., chest pain, elev.
   childr.und.18 yrs not est.   com.pemetrexed in pts. with creatin.clear. &lt; 45 mL/min, tabs:childr./   ALT/AST, nephrotox./hepatotox.& pancreatit.report.with NSAID use
   Side effects: Fluid retent, skin reacts.incl.exfol. dermatit./Stev.-  adolesc.&lt;12 yrs., pregn, galact.intol., Lapp.lact. defic., gluc.-galact.   cannot be ruled out.
   John.syndr./tox.epiderm. necrolys., poss.exacerbat.of GI dis., poss.  malabsorpt., inj.with concom. anticoag.as IM haematomas poss.,   Warnings and special precautions: Prescrib. decis.to be bas.on
   prem.duct. arterios. clos.lead.to pulm.hypertens.in newborn if giv.to   inj.not for IV use.  indiv.pts.overall risks, poss. predisposit. to CV/GI events or cutan.re-
   mothers dur.3  trimest., bld.dyscras., periph.oed., palpitat., hypertens.,   Side effects: GI disturbs./-bleed./-perforat., colit., hepatit., pept.ulc.,   acts.which may be fatal, pre-exist.signific.ren.funct.impairm./ uncom-
        rd
   CHF, CNS effs., GI disturbs. incl. bleed./perforat./ulc., colit./gastrit.  Crohn’s dis., bld.dyscras., skin reacts.incl.Stev.-Johns.syndr.& tox.  pensat. HF/hypertens./liv.cirrhos., monit. ren. & card.funct.& discont.
   induct./ exacerbat., ulcer.stomatit., Chron’s dis.exacerbat., nephrot.  epiderm. necrolys., stomat., urticar., photosensitisat., ac. asthma in   if deteriorat.detect., dehydrat., adeq.hydrat., new onset/recur.CHF, CF
   syndr., glomerulo-/interstit.nephrit., papill. necros., ren. fail., hepatit.,   aspir./other NSAID allerg.pts., alter. mood/ confus./disorientat., CNS   hist., L.ventric.dysfunct., hypertens., pre-exist. oed., comprom.card.
   vis.disturbs., conjunctiv., bronchosp., photosens., flush., tinnit., hyper-  & CV effs., CF, abnorm. ren./liv.funct.paramet., interstit.nephrit., glo-  funct., monit.BP consid.alt. ther. if signif.rise, signfic.CV event risk fact.,
   sens. reacts.incl.anaphylax./angioed.  merulonephrit., papill.necr., nephr.syndr., ac. ren. fail., micturit.disords.,   incr. thrombot.event (MI/stroke) risk incr.with high dos. & long.durat.
   Special precautions: Discont.ther.if GI bleed./ ulcerat., CHF, hyper-  ac.urin.reten., vis. disturbs., vertigo, tinnit., hypersens./anaphylact.   ther., re-eval.treatm.reg., do not discont. anti-platelet ther.& consid.
   tens.hist. &/ HF, incr.GI bleed. & perforat.risk in elderly & with incr.dos.  reacts., flush., inj.site mass/pain, ovulat.delay, fem.infertil.  such ther.if pt.at risk, no evid.that concom.aspirin mitig.incr.in ser.
   in ulc. hist., monit.GI dis.hist.caref.& discont.if ulc./ bleed., discont.  Warnings and special precautions: Fertil.poss. imp. theref.   thrombot.event risk, ischaem.heart dis.hist., incr. risk of skin reacts.
                                                                               st
   immed.in case of skin/hypersens. reacts., monit.concom.Li conc.when   women attempt.to conceive/diffic. conceiv./ und.infertil.investigat.,   in pres.of drug allergy hist., discont. at 1  signs of skin rash/mucos.
               rd
   init./withdr., not recomm.dur.3  trimest.of pregn., monit.ren. funct.  avoid in breast feed., hypertens., card.fail., elderly/debilitat., GI dis.   les./any other hypersens.sign, maintain med.supervis.in elderly & in
   caref.in dehydrat./ren.& hepat.dysfunct./ concom.diurets./past surg.  hist., withdr.if GI bleed./ulcerat.occurs, discont. at 1  sign.of skin rash/  pts.with ren./hepat./card.dysfunct., risk of GI complicat.with NSAID’s,
                                                     st
   lead.to hypovolaem., compromis.card.funct.& other condits.predis-  mucos.les./any sign of hypersens., concom anticoag.treatm., admin.  other concom. NSAID’s/ aspirin, prior GI dis hist., concom. acetylsalic.
   pos. to/ worsen.by fluid retent., discont.immed.in case of bronchosp.  not recomm. with concom.methotrex.dos.of &gt;15 mg/ wk., monit.bld.  acid even at low dos.incr.GI advers. eff. risk, monit.where S&S of liv.
   esp.in case of aspir.sens./asthma/& nasal polyps., poss.decr.IUD effic.  cell count & ren.funct.if concom. methotrex.necess., adeq.hydrat.&   dis.develop & discont.if LFT persist.abnorm., may mask.sympts. of in-
   Drug interactions: Other NSAID & acetylsalicyl. acid may incr.GI   monit.ren.funct. with concom.diurets.prior to admin., tot.dly. dos.   flam./infect., std.INR value monit., monit. methotrex.relat.toxic., avoid
   ulcerat.&/bleed.risk, warfar./ other anticoags. poss.incr.bleed.com-  admin.as tabs./inj.not to exceed 15 mg, concom. alcohol incr.bleed.  concom.aspir dos. above those for CV prophylax., incr.EE & conjug.
   plic.risk, poss. incr.Li plasma conc., poss.incr.haemotolog. toxic. with   risk, incr.risk of ser.CV thrombot. events/MI & stroke incr.with ther.  oestrog. expos.poss. incr.OC & HRT assoc.advers. eff.in women at
   methotrexate, poss.decr.antihypertens. eff. /incr.ren.fail.risk with ACE-  durat., CV dis./ CV dis.risk fact., CHF, dehydrat., liv.cirrhos., ren. dis.,   risk, concom.drugs metabol.by human sulfotransferase (eg. oral sal-
   inhibits./other antihypertens., reduc.eff.with cholestyramine, incr. ne-  dos.not to exceed 7,5 mg in dialys.pts.with sev./ end-stage ren.fail.,   butamol & minoxidil), monit.pt.at high risk of digox.toxic., lact.intol.,
   phrotoxic.risk with cyclosporin., incr.bleed.risk with alcoh., poss. de-  nephrot.syndr., start. treatm. at 7,5 mg/day in pts.with an incr.risk of   monit.ren.funct.with concom. tacrolimus/ cyclosporin.
   hydrat.result.in ren.impairm. with diurets., incr.GI bleed./ulcerat.risk   adv. reacts., maj.surg.proced.which lead to hypovolaem., Na , K  &   Drug interactions: Nephrotox.of cyclosporin & tacrolimus poss.
                                                           +
                                                          +
   with corticoster., incr.GI bleed.risk with anti-platel. agents & SSRI’s.  H 2O retent.induc. interfer.with natriuret.eff.of diuret, discont.in case   enchanc., incr.prothromb.time with warfar., plasma conc.decr.with
                                                              rifampic, methotrex. plasma conc.poss.incr., antihypetens. eff.of
   MELZY, Zydus [P/S]           of signific./persist.seru.transamin.abnormalit., underly. infect. dis.  ACE inhibit./angiotensin II antagon.& diuret. poss. dimin., in ren.
   Meloxicam.                   sympts.poss.mask., monit.Li plasma conc.dur.init./adj.& withdraw.,   impairm.ren.funct.poss.furth. deterior.with concom.ACE inhibit./
   Indications: Rheumat.arthrit., painf.osteoarthrit., ankylos. spondy-  monit.pt. for myelosuppress. & GI adv.reacts.with concom. peme-  angiotensin II antagon., plasma Li lev.poss.incr., steady state AUC
   lit., ac.sciatica episodes   trexed., pause admin.for 5 days bef./on the day of & 5 days follow.  of OC ethinyl estradiol & HRTconjug.oestrog. incr., eff.of furosemide
   (S3) TABS, 37/3.1/0267, 0268  pemetrexed admin in pts. with creatin.clear. from 45-79 mL/min,  & thiazide poss.reduc., C max of digox. incr., AUC incr.by ketoconazole
   705229-001: 7,5 mg, 30, R34,68  Interactions: Concom.prostaglandin synthetase inhibit.incl.NSAIDs/  (potent CYP3A4 inhibit.).
   705230-001: 15 mg, 10, R25,01  salicylates may incr. risk of side effs., incr.risk of GI perforat./ulcerat./
   705230-002: 15 mg, 30, R75,08  bleed. with corticoster., incr.bleed.risk with oral anticoags./ system.  ARCOXIA, MSD [P/S]
   Dosage: Admin.with food. Max.dly.dos: 15 mg.  hepar./thrombolyts., incr. risk of GI bleed with antiplatelet drugs.&   Etoricoxib.
   Ac.sciatica: 7,5 mg once dly.incr.to 15 mg dly.if no improvem.  SSRI’s, incr. plasma Li lev., incr.haematolog.toxic.of methotrexate,   Indications: Symptomat.relief of osteoarthrit.& rheumat.arthrit.,
   Ankylos.spondylit: 15 mg once dly.  decr.effic.of IUD’s, reduc.eff.of antihypertens. drugs (ß-block./ACE-  ac.gouty arthrit., ankylos. spondylit., ac.pain.max.8 days, prim.dys-
   Osteoarthrit: 7,5 mg once dly. incr.to 15 mg if necess.  inhibit. /vasodilat. & diuret.), angiotens.-II recept.antagon. & ACE   menorrh., mod.to sev.ac.dent.surg.post-op pain.
   Rheumat.arthrit: 15 mg once dly, reduc.if poss. provid.therapeut.  inhibit.decr.glomerul.filtrat., probenecid reduc. excret., cholestyramine   (S3) TABS, 37/3.1/0399, 0400, 0401
   respons.maint.               incr.elimin., nephrotox. of cyclosporin enchanc., do not combin. with   709108-001: 60 mg, 28, R319,86
   Contraindications: Asthma attacks/urticar/ nasal polyps or   tracrolimus, potent.interact.with meds.known to inhib./be metabol.  709109-002: 90 mg, 28, R322,99
   ac.rhinit.precipitat.by aspir./NSAID’s, act. pept.ulc.dis., sev.hepat./  by CYP2C9 &/or CYP3A4, poss. incr.plasma lev.of Mobic & oral an-  709110-001: 120 mg, 7, R96,78
   non-dialys.ren. impairm., safety in pregn./lactat.not est.  tidiabet. (sulphonylures/nateglinide) theref.monit.for hypoglycaem.,   709110-002: 120 mg, 28, R387,09
   Side effects: Freq: Anaem., oed., headache, dizzin., light-headedn.,   incr.bleed. with alcoh.  Dosage:.Short.durat.& low.effect.dos. Recomm. dos. are max.dos.
   dyspeps., N&V, diarrh., flatul., constipat., abdom.pain, prurit., rash. Less   Osteoarthrit: Recomm.dos: 30 mg or 60 mg once dly.
   freq: Trombocytopen., neutropen., eosinophil., agranulocytos., leuco-  Rheumat.arthrit: Recomm.dos: 90 mg once dly.
   pen., palpitat., elev.BP, vertigo, confus., drowsin., insomn., nightmares,   4.1.3   Specific cyclo-   Ankylos.spondylit: Recomm.dos: 90 mg once dly.
   GI bleed./perforat./ulcerat., colit.induct./exacerbat., gastrit., nephrot.  Ac.pain: Recomm.dos: 90 or 120 mg once dly. limit.to max.8 days.
   syndr., glumerulonephrit., interstit. nephrit., papill.necros., ren.fail.,   oxygenase-2 inhibitor   Ac.gouty arthrit: Recomm.dos: 120 mg once dly. limit.to 8 days
   hepatit., vis. disturbs., conjunctivit., bronchosp., flush., urticar., stomatit.,   Prim.dysmenorrh: Recomm.dos: 120 mg once dly.
   photosens., bullous dermatos. incl. erythema multiforme/Stev.-Johns.  Post-op dent.pain: Recomm.dos: 90 mg once dly.
   syndr.& tox. epiderm. necrolys., tinnit., hypersens.reacts.incl. anaphy-  (COXIB)  Contraindications: Act.pept.ulcerat./GI bleed., sev. hepat.dysfunct.,
   lax./ angioed.& bronchosp.esp.in aspir. sens./ asthmat./nas. polyps,  COXLEON (MDR Listing)  est.creatinine clear.&lt;30 ml/ min., S&S’s of aspirin/other NSAID’s
   Warnings and special precautions: Safety in childr. und. 18 yrs.not est.,   RAYZON (MDR Listing)  cross-sens., uncontrol.hypertens., pregn.& lactat., childr./ adolesc.
   GI bleed., hepat./ren. impairm., CHF, GI dis.hist.discont.if ulcerat./bleed. oc-  und.16 ys., inflamm.bowel dis., CHF (NYHA II- IV), est.ischaem.heart
   curs, determ.CNS or vis.effs.bef.driv./operat. machin., monit.ren.funct.in de-  ADCO ETORICOXIB, AI Pharm [P/S]  dis.and/or cerebrovasc.& periph.arter.dis., peri-op.pain in coron.artery
   hydrat./HF/hepat.or ren. dysfunct./ diuret.ther.& surg.lead to hypovolaem.  Etoricoxib.  bypass graft surg.setting., not recom. in women attempt.to conceive.
   Interactions: Other NSAID’s/aspir.may incr. GI ulcerat./bleed.risk,   Indications: Symptomat.relief of osteoarthrit.& rheumat.arthrit.,   Side effects: Fluid retent., oed., hypertens. which may be more
   anticoags.incr.bleed.complicat. risks, Li plasma conc.incr., incr.haema-  ac.gouty arthrit., ankylos. spondylit., ac.pain.max.8 days, prim.dys-  freq.& more sev.partic.at high dos., poss.fatal ser.skin reacts., ser.
   tolog. toxic. due to methotrex.toxic., decr.eff.of antihypertens. agents   menorrh., mod.to sev.ac.dent.surg.post-op pain.  hypersens. reacts.incl.anaphylax.& angioed., alveolar osteit., gastro-</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page104.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page100.html">100</a>&nbsp;&nbsp;&nbsp;<a href="page101.html">101</a>&nbsp;&nbsp;&nbsp;<a href="page102.html">102</a>&nbsp;&nbsp;&nbsp;<a href="page103.html">103</a>&nbsp;&nbsp;&nbsp;<a href="page104.html">104</a>&nbsp;&nbsp;&nbsp;<a href="page105.html">105</a>&nbsp;&nbsp;&nbsp;<a href="page106.html">106</a>&nbsp;&nbsp;&nbsp;<a href="page107.html">107</a>&nbsp;&nbsp;&nbsp;<a href="page108.html">108</a>&nbsp;&nbsp;&nbsp;<a href="page109.html">109</a>&nbsp;&nbsp;&nbsp;<a href="page110.html">110</a>
             </td>
             <td width="35%"><a href="page106.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page106.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
